Precision Rx Compounding, LLC et al. v. Express Scripts Holding Company et al.Date Filed: January 15, 2016
District Court: E.D. Missouri – Case No. 4:16-CV-00069
Nature of Suit: Antitrust
Defendant Type: Pharma
Plaintiff Type: Private
Court Document: https://cases.justia.com/federal/district-courts/missouri/moedce/4:2016cv00069/144109/62/0.pdf?ts=1472118881
In January 2016, several independent compounding pharmacies sued pharmacy benefit manager Express Scripts, accusing it and CVS Health Corp., OptumRx Inc. and Prime Therapeutics LLC of cutting the compounding pharmacies from the market in violation of federal and state antitrust laws. The suit was brought in federal court in Missouri. The defendants’ motion to dismiss was denied on August 24, 2016 and the case was set for a jury trial on January 7, 2019. On May 31, 2018, both parties stipulated to dismiss plaintiffs’ claims in this action with prejudice; however, Defendants’ pending counterclaims are still pending and the case continues to be in discovery as of July 2018.